- $5.70bn
- $6.39bn
- $4.48bn
- 91
- 68
- 57
- 83
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,521 | 3,709 | 4,022 | 4,371 | 4,477 |
Cost of Revenue | |||||
Gross Profit | 1,226 | 1,291 | 1,432 | 1,536 | 1,571 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,091 | 3,271 | 3,513 | 3,869 | 3,846 |
Operating Profit | 429 | 439 | 509 | 502 | 631 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 399 | 400 | 483 | 465 | 602 |
Provision for Income Taxes | |||||
Net Income After Taxes | 305 | 308 | 369 | 353 | 631 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 305 | 308 | 369 | 353 | 631 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 305 | 308 | 369 | 353 | 631 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.6 | 1.77 | 1.92 | 2.1 | 3.4 |
Dividends per Share |